538 results
Essential drugs that every interventionalist needs to know
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.
How should I treat STEMI?
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, watch a series of STEMI cases and learn more about left main stem, bifurcation, imaging, large thrombus situation, and cardiogenic shock in this particular context and follow the ensuing discussions to be better prepared if you were ever faced with it yourself.
Distal vs conventional radial access for coronary angiography and/or intervention: a meta-analysis of randomized trials
30 Nov 2022
The present systematic review and meta-analysis by Ferrante et al aimed to provide a comprehensive quantitative analysis of the effects of DRA vs TRA, by pooling data from randomised controlled trials (RCT) comparing these two access sites when used for coronary angiography and/or percutaneous coronary intervention...

Reviewer

Reviewer
A leaking left main or a leaking stent shaft !?
23 Nov 2022
Contrast staining during coronary angioplasty is an ominous sign, usually indicating deep artery wedging by the guide catheter, or vessel dissection / perforation. The author presents an unusual cause of LMCA staining during primary LAD PCI.

Author
Aspirin vs Clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study
08 Nov 2022
The HOST-EXAM trial1 was a prospective, randomised, open-label trial investigating clopidogrel monotherapy versus aspirin therapy in patients undergoing PCI with DES who had completed 6-18 months of DAPT with no ischaemic or bleeding complications. At 24 months follow-up, clopidogrel monotherapy significantly reduced the risk of the...

Reviewer
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.

Author
AHA 2022: get the interventional cardiology perspective!
07 Nov 2022
Stay up to date with what is new and hot in interventional cardiology at #AHA22 in Chicago.
A patient with ACS – how should I treat the left main?
31 Oct 2022
Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.
Optical coherence tomography fractional flow reserve and cardiovascular outcomes in patients with acute coronary syndrome
18 Oct 2022
Optical Coherence Tomography fractional flow reserve (OCT-FFR) has been shown to correlate well with wire-based FFR; however, clinical outcomes based on OCT-FFR are not well defined. In this retrospective study, the authors sought to investigate the relationship between OCT-FFR and long-term clinical outcomes in ACS.

Reviewer